Meyer SC (2009) Signature in the Cell. DNA and the Evidence for Intelligent Design. HarperCollins Publishers, New YorkMeyer, S. (2009). Signature in the Cell. New York: HarperOne.Meyer, Signature in the Cell, chapter 17.Meyer, S.C., Signature in the cell, HarperOne, New York 2009,...
《Signature in the Cell》(Meyer, Stephen C.)内容简介: All of us are looking for ways to take control of our lives, whether in our relationships, our fam...
Signature in the CellBy Stephen C. Meyer The Mystery of Life’s Origin: The Continuing Controversy themysteryoflifesorigin.com Philosopher of science Stephen C. Meyer wrote a new chapter on the current state of the origin-of-life debate. ...
Signature in the Cell 来自 harpercollins.com 喜欢 0 阅读量: 44 作者: SC Meyer 摘要: The article reviews the book "Signature in the Cell: DNA and the Evidence for Intelligent Design," by Stephen C. Meyer. 被引量: 278 年份: 2010 ...
Meyer, S. et al. AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies. Cell 166, 582–595 (2020). Google Scholar Shankar-Hari, M. et al. Activation-associated accelerated apoptosis of memory B cells in critically Ill patients with sepsis. Crit. Care Med. 45...
作者: Stefanie Meyer,Anja Bosserhoff,Ferdinand Hofstdter,Armin Pauer,Michael Landthaler 摘要: BACKGROUND: Current staging methods such as tumor thickness, ulceration and invasion of the sentinel node are known to be prognostic parameters in patients with malignant melanoma (MM). However, ...
TYROBP (tyrosine kinase binding protein) is a transmembrane polypeptide that expressed in several cell types, including peripheral blood monocytes, macrophages, natural killer cells, dendritic cells, and osteoblasts29. In central nervous system (CNS), TYROBP mainly expressed in microglia and ...
In addition, relapse-free survival (RFS) was compared by the Kaplan-Meyer method. Classification according to the IBC signature is significantly (P < 0.05) associated with the cell-of-origin subtypes, the wound healing response, the invasive gene signature, the genomic grade index, the ...
The TCGA validation cohort was enriched for high age (p = 0.03), high FIGO stage (p < 0.001) and squamous cell carcinomas (p < 0.001) when compared to the population-based cohort. The clinicopathological features were compared between recurrent and non-recurrent tumours in the ...
CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data ArticleOpen access09 September 2021 Introduction Somatic mutations accumulate throughout our lifetime, arising from external sources or from processes intrinsic to the cell1,2. Some sources...